CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

CCTA-based approach

CCTA is a Class 1, Level A frontline testing strategy for chest pain.

6 min read

The Benefits of Cardiac CT Angiogram as a Diagnostic Tool

When patients present to physicians with an elevated risk of coronary artery disease, or CAD, cardiologists have many tests at their disposal....

Read More »

4 min read

Cleerly Versus Coronary Artery Calcium Score: How the two heart disease tests measure up

Both coronary artery calcium score (CACS) and Cleerly evaluate heart disease risk using cardiac imaging. Learn about the key differences between the...

Read More »
Cleerly’s precision heart care helps health systems

4 min read

Cleerly Value to Health Systems: Precision Heart Care Reduces Risk and Improves Patient Care

Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to...

Read More »
Cleerly's precision heart care creates value for health plans

2 min read

Cleerly Value to Health Plans: Precision Heart Care Reduces Waste and Improves Patient Experience

Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into...

Read More »
Cleerly’s precision heart care enables providers to improve patient outcomes & satisfaction

3 min read

Cleerly Value to Private Practice: Precision Heart Care Allows for Personalized Heart Disease Evaluation

Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease...

Read More »
CCTA scan results

2 min read

What to Expect with a CCTA Scan

Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA)...

Read More »

3 min read

Transforming Cardiac Care: A New Cleerly Webinar Series

There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.

Read More »

1 min read

Cleerly CEO Featured on AWS Health Innovation Podcast

Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.

Read More »
Cleerly's CLARIFY 2 study demonstrates the efficacy of its non-invasive AI-enabled CCTA approach for heart disease evaluation

3 min read

CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods

Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease...

Read More »

2 min read

Cleerly Product Release:  Taking Precision Heart Care to the Next Level

As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...

Read More »